These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19474420)

  • 41. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 42. Evaluation of a novel device for left atrial appendage exclusion: the second-generation atrial exclusion device.
    Kamohara K; Fukamachi K; Ootaki Y; Akiyama M; Cingoz F; Ootaki C; Vince DG; Popović ZB; Kopcak MW; Dessoffy R; Liu J; Gillinov AM
    J Thorac Cardiovasc Surg; 2006 Aug; 132(2):340-6. PubMed ID: 16872960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anticoagulation interruptus: not without risk.
    Ezekowitz MD
    Circulation; 2004 Sep; 110(12):1518-9. PubMed ID: 15381656
    [No Abstract]   [Full Text] [Related]  

  • 44. Percutaneous left atrial appendage transcatheter occlusion in patients with chronic nonvalvular atrial fibrillation: early institutional experience.
    Ussia GP; Mangiafico S; Privitera A; Mulè M; Caruso E; Galassi AR; Famoso G; Tamburino C
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):569-72. PubMed ID: 16858233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Transesophageal echocardiography in patients with atrial fibrillation, candidates for cardioversion: usefulness and limitations].
    Antonielli E; Pizzuti A; Gandolfo N; Bosco M; Sclavo M; Magnacca M; Leonardi G; Doronzo B; Baralis G; Di Leo M
    G Ital Cardiol; 1995 May; 25(5):543-52. PubMed ID: 7642059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thromboprophylaxis in atrial fibrillation: why, how, when and how can we do better?
    Watson T; Lip GY
    Int J Clin Pract; 2006 Mar; 60(3):252-5. PubMed ID: 16494636
    [No Abstract]   [Full Text] [Related]  

  • 47. A novel device for left atrial appendage exclusion.
    Kamohara K; Fukamachi K; Ootaki Y; Akiyama M; Zahr F; Kopcak MW; Dessoffy R; Popović ZB; Daimon M; Cosgrove DM; Gillinov AM
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1639-44. PubMed ID: 16308010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel device for left atrial appendage exclusion: the third-generation atrial exclusion device.
    Fumoto H; Gillinov AM; Ootaki Y; Akiyama M; Saeed D; Horai T; Ootaki C; Vince DG; Popović ZB; Dessoffy R; Massiello A; Catanese J; Fukamachi K
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):1019-27. PubMed ID: 18954645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antiarrhythmic prophylaxis vs warfarin anticoagulation to prevent thromboembolic events among patients with atrial fibrillation. A decision analysis.
    Middlekauff HR; Stevenson WG; Gornbein JA
    Arch Intern Med; 1995 May; 155(9):913-20. PubMed ID: 7726699
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Several alternatives for stroke prophylaxis in atrial fibrillation].
    Olsson SB
    Lakartidningen; 2004 Oct; 101(41):3156, 3158-9. PubMed ID: 15517711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Closing in on ending the warfarin era for stroke prevention in nonvalvular atrial fibrillation.
    Turi ZG
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):223-4. PubMed ID: 19642149
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute management of atrial fibrillation: Part II. Prevention of thromboembolic complications.
    King DE; Dickerson LM; Sack JL
    Am Fam Physician; 2002 Jul; 66(2):261-4. PubMed ID: 12152961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study.
    Lorenzoni R; Lazzerini G; Cocci F; De Caterina R
    Am Heart J; 2004 Jul; 148(1):e6. PubMed ID: 15215815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion?
    Dawson AG; Asopa S; Dunning J
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):306-11. PubMed ID: 19942634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Left Atrial Appendage Closure: Continuous Progress With Remaining Challenges.
    Sievert H; Bertog S
    JACC Cardiovasc Interv; 2017 Nov; 10(21):2195-2197. PubMed ID: 29122134
    [No Abstract]   [Full Text] [Related]  

  • 56. Not all thromboembolism comes from the left atrial appendage in atrial fibrillation.
    Senoo K; Lip GY
    Heart; 2015 Jun; 101(11):830-1. PubMed ID: 25753117
    [No Abstract]   [Full Text] [Related]  

  • 57. [Multimorbid patients - numerous illnesses, numerous therapies: a challenge due to interactions].
    Siebenhuener K; Meindl-Fridez C; Holzer BM; Battegay E
    Praxis (Bern 1994); 2016 Feb; 105(4):183-91; quiz 189-90. PubMed ID: 26886693
    [No Abstract]   [Full Text] [Related]  

  • 58. Percutaneous Left Atrial Appendage Closure: How Easy Can it Get?
    Meier B
    J Invasive Cardiol; 2015 Dec; 27(12):E302. PubMed ID: 26477045
    [No Abstract]   [Full Text] [Related]  

  • 59. Summary for Patients: Occlusion Devices Versus Blood Thinners for Atrial Fibrillation.
    Ann Intern Med; 2022 Sep; 175(9):I28. PubMed ID: 35969860
    [No Abstract]   [Full Text] [Related]  

  • 60. Exploring the dark side of left atrial appendage closure devices.
    Santangeli P; Epstein AE
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):14-16. PubMed ID: 28988462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.